Authors: Kavanaugh, A St Clair, EW McCune, WJ Braakman, T Lipsky, P

Citation: A. Kavanaugh et al., Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment ofpatients with rheumatoid arthritis receiving methotrexate therapy, J RHEUMATOL, 27(4), 2000, pp. 841-850

Authors: Present, DH Rutgeerts, P Targan, S Hanauer, SB Mayer, L van Hogezand, RA Podolsky, DK Sands, BE Braakman, T DeWoody, KL Schaible, TF van Deventer, SJH

Citation: Dh. Present et al., Infliximab for the treatment of fistulas in patients with Crohn's disease, N ENG J MED, 340(18), 1999, pp. 1398-1405

Authors: Rutgeerts, P D'Haens, G Targan, S Vasiliauskas, E Hanauer, SB Present, DH Mayer, L Van Hogezand, RA Braakman, T DeWoody, KL Schaible, TF Van Deventer, SJH

Citation: P. Rutgeerts et al., Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease, GASTROENTY, 117(4), 1999, pp. 761-769

Authors: D'Haens, G Van Deventer, S Van Hogezand, R Chalmers, D Kothe, C Baert, F Braakman, T Schaible, T Geboes, K Rutgeerts, P

Citation: G. D'Haens et al., Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial, GASTROENTY, 116(5), 1999, pp. 1029-1034